Fluvastatin-D8 (Major) Sodium Salt

• 产品号: F601252
• CAS号: 1260178-87-7
• 分子式: C24H25FNNaO4
• 分子量: 433.4477732
• 保 存: -20°C Freezer, Under Inert Atmosphere

产品别名

• 标题: Fluvastatin-D8 (Major) Sodium Salt
• IUPAC标准名: sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-[(^2H₇)propan-2-yl](5,7-^2H₂)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate
• IUPAC传统名: sodium (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-[(^2H₇)propan-2-yl](5,7-^2H₂)indol-2-yl]-3,5-dihydroxyhept-6-enoate
• 别名: Lescol-D8; (3R,5S,6E)-rel-7-[3-(4-Fluorophenyl)-1-(1-methylethyl-deuterated)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt; Lipaxan-D8; Fluindostatin-D8; XU 62-320-D8; Primexin-D8

产品登记号

• CAS号: 1260178-87-7

产品性质

• 外观: Yellow to Light Orange Solid
• 熔点: 194-197°C
• 溶解度: Methanol
• 溶解度: Water
• 保存条件: -20°C Freezer, Under Inert Atmosphere

产品详细信息

详细说明 (English)

A synthetic HMG-CoA reductase inhibitor. Antilipemic.A representative lot was: 1% of d6, 28% of d7, 37% of d8, 21% of d9, 10% of d10, and 2% of d11

参考文献

• Yuan, J., et al.: Atherosclerosis, 87, 147 (1991)
• Tse, F.L.S., et al.: J. Clin. Pharmacol., 32, 630 (1991)
• Dain, J.G., et al.: Drug Metab. Disposit., 21, 567 (1991)